Bull Rankings model

Balchem Corporation (BCPC) stock analysis

Specialty Chemicals. Scored on the same transparent model behind the daily rankings.

★
BCPC
Balchem Corporation · Specialty Chemicals
52.2Score
$167.83Oct 9 close$5.4B
1Y Target$209.25Analyst consensus · 4 analysts
5Y Target$306.36Compound horizon
10Y Target$454.47Long-dated conviction
FCF$176mTTM · 03/26
C
FCF $176m — modest; watch for margin expansion · Trailing twelve months to 03/26 (operating cash flow − capex).
Rev+8.8%FY YoY
B
Revenue +8.8% — at or above S&P median · Computed from the last two annual revenue figures (FY YoY).
D/E0.13
A-
D/E 0.13 — less debt than most Basic Materials peers (≈25th pctile)
P/E33.2x
C
P/E 33.2 — expensive vs Basic Materials peers (≈90th pctile)
PEG3.26
D
PEG 3.26 — very expensive; pricing in best-case scenarios

Targets: 1-year is analyst consensus where covered, 5- and 10-year are model estimates; the DCF is a cross-check, not a target. Methodology

Quality-growth score · 52.2
Quality74.8
Growth50.0
Value38.1
Why this score
  • Raising its dividend
  • Cyclical growth
Entry · Margin of safety
52-week rangeMid-range
9% off the 12-month high
vs DCF fair value65% aboveest. fair value ~$102
What the price assumes: free cash flow growing about 19% next year, slowing to 4% a year by year ten — vs a starting rate of ~8% our model takes as the middle of three readings — analyst estimates, last year's revenue growth, and the company's own multi-year record.

Model-generatedFrom reported fundamentals, checked against the figures above · Editorial standards

Why now
Specialty Chemicals · market cap $5.4b. 9% off the 52-week high of $183.90. 4 sell-side analysts publish a mean 1-yr target of $209.25 (implying +25% upside).
Moat
Net margin 15% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 107% of net income — earnings translate cleanly into cash.
Risk
Trailing P/E 33x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Horizon
1-3 yr $209.25 (4-analyst consensus) — fundamentals + valuation re-rating. 5 yr $306.36 at ~13% CAGR — compounding case rests on the competitive position widening. 10 yr $454.47 if current growth sustains into durable earnings power.

BCPC vs the Top Picks average

PillarBCPCBook avgDiff
Quality7583-8
Growth5089-39
Value3876-38

Average of today's Top 30 (mean score 82.6); size and sector limits also decide the book.

Trend
-0.9 over 82 daily scores
From 53.1 (Jun 22) → 52.2 (now)

One point per daily run; read From → To for the actual range.

BCPC at a glance

THE BULL RANKINGS SCORECARD52.2/ 100 · BULL SCOREPEER MEDIANQUALITY74.8GROWTH50.0VALUE38.1Reverse-DCF · Price implies ~19% growth a year from here.
PRICE vs OUR DCF FAIR VALUE$96.3$110FAIR-VALUE RANGE$168PRICEOur DCF fair value ~$102 · price $168 is 65% above it.
ONE-YEAR MOVE VS ITS BETAFLATThis stock+17%Trailing one-year price change. Price history is not an inputto the Bull Rankings score.
PRICE IN ITS 52-WEEK RANGE$168LOW $140HIGH $184Trading at the 63rd percentile of its 52-week range ($140–$184).

Same audited fundamentals as the score, unless a card says otherwise.

Analyst estimate revisions

30-day change+0.0%
90-day change+2.7%
Forward EPS estimate$6.27

Over the last 90 days, what analysts expect BCPC to earn is drifting higher (+2.7%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →

Shares to buy
11
Position size
$1,846
3.7% of portfolio
Stop price
$125.87
25% below $167.83
$ at risk if stopped
$461.53
budget $500.00 · 1% of portfolio

Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.

Balchem Corporation (BCPC): score, valuation & FAQ

Balchem Corporation (BCPC) is a Specialty Chemicals company that scores 52.2 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are D/E (A-), while PEG (D) rate weaker. On valuation, BCPC sits about 65% above our discounted-cash-flow fair value — the current price implies free cash flow growing about 19% next year, slowing to 4% a year by year ten.

Is BCPC a good stock to buy?

Bull Rankings scores BCPC 52.2 out of 100 on its quality-growth model, which is a middling reading. That is driven by D/E (A-). A score is a quantitative screen of Balchem Corporation's fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does BCPC score 52.2 on Bull Rankings?

The score leans on quality at 74.8 out of 100, with value the weakest pillar at 38.1 — the three combine geometrically, so a weak one cannot be papered over by a strong one. BCPC earns its highest marks on D/E (A-), and is held back by PEG (D). Each signal is graded against sector-aware thresholds rather than one absolute bar, so BCPC is measured against Specialty Chemicals peers, not against the market as a whole.

Is BCPC overvalued or undervalued?

Based on $167.83, BCPC sits about 65% above our discounted-cash-flow fair value — the current price implies free cash flow growing about 19% next year, slowing to 4% a year by year ten. It trades at a 33.2x P/E (graded C). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in BCPC?

Trailing P/E 33x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.

New to these metrics? See the guides and the methodology.

More Chemicals stocks by score

All Basic Materials rankings →

Analyze another ticker →